Esomeprazole Strontium
Product Images NDC 69336-129

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Esomeprazole Strontium (NDC 69336-129). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sterling-knight Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Esomechemicalstructure (Esomechemicalstructure)

Chemical structure of Esomeprazole strontium, showing the molecular arrangement including the strontium ion complex and hydration with four water molecules as indicated.*

FDA Label Image

Esomeprazolelabel (Esomeprazolelabel)

Label for Esomeprazole strontium delayed-release capsules 49.3 mg, containing 30 capsules per bottle. The label shows the NDC number 69336-129-30 and states the product is RX only. It is manufactured for Sterling-Knight Pharmaceuticals, LLC, Ripley, MS. The label includes storage instructions, a barcode, and a purple and blue color scheme.*

FDA Label Image

Figure2 (Figure2)

A line graph titled 'Maintenance of Healing Rates by Month (Study 177) - Esomeprazole Magnesium' showing percent maintained on the vertical axis and months on the horizontal axis. Four lines represent Esomeprazole Magnesium doses of 44.6 mg, 22.3 mg, 11.15 mg, and placebo, tracked over six months with scheduled visits noted.*

FDA Label Image

Figure3 (Figure3)

A line chart titled 'Maintenance of Healing Rates by Month (Study 178) - Esomeprazole Magnesium' showing percent maintained healing over six scheduled visits/months. Four groups are plotted: Esomeprazole Magnesium 44.6 mg, 22.3 mg, 11.15 mg, and placebo, with healing rates generally decreasing over time, placebo showing the steepest decline.*

FDA Label Image

Figure4 (Figure4)

A line graph showing the percent of patients symptom-free of heartburn by diary day over 28 days. It compares three groups: Esomeprazole Magnesium 44.6 mg, Esomeprazole Magnesium 22.3 mg, and placebo. The y-axis represents percent of patients symptom-free, and the x-axis shows diary days from 0 to 28.*

FDA Label Image

Figure5 (Figure5)

A line graph titled 'Percent of Patients Symptom-Free of Heartburn by Day (Study 226) - Esomeprazole Magnesium' displaying three data series over 28 days. The y-axis represents the percent of patients symptom-free, ranging from 0 to 100%, and the x-axis shows diary days from 0 to 28. The graph compares Esomeprazole Magnesium at 44.6 mg, 22.3 mg, and placebo groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.